It has been reported that genetically predicted high IGF-1 levels are associated with reduced COVID-19 susceptibility and risk of hospitalization (42), and diabetic patients tend to have reduced blood levels of IGF-1, which may be an important reason why diabetes is a risk factor for death in COVID-19 patients. The gene discussed is IGF1; the disease is COVID-19.